GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: compound B [WO2022002018A1] | LY-3499446
Compound class:
Synthetic organic
Comment: LY3499446 is a direct inhibitor of oncogenic KRAS mutant G12C that was developed for anticancer potential [1].
|
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
IUPAC Name ![]() |
| 1-[4-[7-(2-amino-7-fluoro-1,3-benzothiazol-4-yl)-6-chloro-8-fluoroquinazolin-4-yl]piperazin-1-yl]prop-2-en-1-one |
Synonyms ![]() |
| compound B [WO2022002018A1] | LY-3499446 |
Database Links ![]() |
|
| CAS Registry No. | 2409131-50-4 (source: PubChem) |
| GtoPdb PubChem SID | 472319188 |
| PubChem CID | 146472812 |
| Search Google for chemical match using the InChIKey | YNBBKDMAVRSYRE-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | YNBBKDMAVRSYRE |
| UniChem Compound Search for chemical match using the InChIKey | YNBBKDMAVRSYRE-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | YNBBKDMAVRSYRE-UHFFFAOYSA-N |
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖